VynMed holds a granted U.S. utility patent.
Issued to founder Walter Bischoff Jr, VynMed Inc. owns a granted U.S. utility patent for the original reusable infection-screening method the company was built on.
What the patent describes
US Patent 12,308,098 B1, "Personal and reusable infection status passport device," describes a countertop device and associated method that combines sample intake, secure chain-of-custody, on-device verification, and tamper-evident reporting in a single, facility-owned workflow.
It reflects the company's origins: a reusable, facility-controlled approach to turning a point-of-care test into a defensible, auditable record.
Independent claims at a glance
- A reusable, personal infection-screening unit.
- An on-device chain-of-custody step that binds sample, timestamp, and identity before any result is surfaced.
- A reporting pipeline that produces a tamper-evident record suitable for regulatory, clinical, and forensic review.
Why a granted patent matters
Examined IP
VynMed's core method was examined and granted by the USPTO, not merely filed — a credibility signal for partners and buyers evaluating the company.
Method, not consumable
The granted claims are directed at a reusable verification method rather than any single strip, reagent, or supplier.
Foundation to build on
The invention spans related verification use cases (infection status, medication adherence, occupational health), giving VynMed an IP foundation to build from.
Patented vs. patent-pending
Most hardware startups in this category wave around a provisional filing. VynMed's core IP is a granted United States utility patent, already examined and issued by the USPTO. The claims have been through substantive review, not just paid for and stamped "pending."
If you need the exact file wrapper or want your counsel to review the claims directly, we're happy to share the issued patent document under a short evaluation NDA.
Want to see VynMed in action?
Book a 20-minute walkthrough of the device, the on-site workflow, and how we make the result defensible from sample to signature.
Request a demo